Genotyping and gene sequencing reveal limited diversity in a live Theileria parva vaccine.
Two of the vaccine components show a high level of similarity at all loci.
The vaccine contains very little of the diversity found in field T. parva.
The vaccine is suboptimal for generating immunity again diverse parasite strains.
The presence of minor genotypic components poses difficulties for quality control.